Table 1.
Demographic data and disease profile of the two groups
| Patient profile | Median (IQR) | P | |
|---|---|---|---|
| WAP (n=20) | Betamethasone (n=21) | ||
| Age* (years), mean±SD | 25.85±1.84 | 25.90±1.17 | 0.98 |
| Gender | |||
| Male** | 16 (80) | 13 (61.9) | 0.31 |
| Female** | 4 (20) | 8 (38.1) | |
| Total duration of illness (years) | 3.5 (1.58-8) | 5 (1-7) | 0.69 |
| Duration of current episode (years) | 1.58 (0.63-3) | 1 (0.4-2) | 0.39 |
| Average SALT score at baseline | 24 (14-58) | 19 (14-55) | 0.94 |
| Involvement of body sites other than scalp | 6 (30) | 7 (33.33) | 0.82 |
| Number of patients with first episode of AA | 13 (65) | 11 (52.4) | 0.41 |
| Number of patients with recurrent AA | 7 (35) | 10 (47.6) | |
*Data expressed in mean±SD, **Data expressed as frequency (%). IQR: Interquartile range, SD: Standard deviation, SALT: Severity of Alopecia Tool, AA: Alopecia areata, WAP: Weekly azathioprine pulse